Glucose 5% Com Cloreto De Sódio 0,9% Basi

Glucose 5% and Sodium Chloride 0.9% Injection is an intravenous solution containing 5 % w/v glucose and 0.9 % w/v sodium chloride. It is supplied as a sterile injection solution intended for infusion into the bloodstream. The product is classified as an intravenous electrolyte solution and is used for fluid and electrolyte replacement. It is marketed in the European Union and requires a prescription for adult and pediatric patients.

Glucose 5% and Sodium Chloride 0.9% Injection is indicated for several clinical situations where fluid, electrolyte, and energy support are required.

- Replacement of extracellular fluid losses due to surgery, trauma, or burns. - Maintenance of hydration in patients unable to take oral fluids. - Prevention or treatment of hypoglycemia when a rapid glucose source is needed. - Electrolyte balance in patients receiving parenteral nutrition or diuretic therapy. - Support during diagnostic or therapeutic procedures that require intravenous fluid administration.

Adverse reactions to the solution are generally related to the infusion itself or to the constituents.

Common: - Mild local irritation at the infusion site. - Transient increase in blood glucose levels. - Slight electrolyte shifts causing mild nausea or headache. - Low-grade fever or chills during rapid infusion. - Local phlebitis with redness and swelling.

Serious: - Hyperglycemia requiring medical intervention. - Severe electrolyte imbalance such as hyponatremia or hypernatremia. - Allergic reaction manifesting as rash, urticaria, or anaphylaxis. - Fluid overload leading to pulmonary edema. - Cardiovascular instability such as hypotension or arrhythmia.

Before using Glucose 5% and Sodium Chloride 0.9% Injection, clinicians should consider several precautionary measures to ensure patient safety.

- Assess blood glucose and electrolyte levels prior to initiation. - Adjust infusion rate in patients with renal or cardiac impairment. - Use caution in individuals with known hypersensitivity to any component. - Monitor for signs of fluid overload, especially in elderly or critically ill patients. - Avoid rapid bolus administration unless specifically indicated. - Verify compatibility with other intravenous medications before co‑administration. - Document the indication and volume administered in the patient record.

The solution may interact with certain drugs or clinical conditions; awareness of these interactions helps prevent complications.

Avoid: - Concurrent administration of high‑dose insulin without glucose supplementation. - Use with hypertonic saline solutions that could exacerbate electrolyte disturbances. - Mixing with drugs that are incompatible with chloride ions, such as certain calcium preparations.

Use with caution: - Concurrent diuretics that may alter sodium balance. - Vasopressors that can affect peripheral circulation at the infusion site. - Blood products, requiring separate lines to avoid precipitation. - Medications that affect glucose metabolism, such as glucocorticoids.